| |
|
|
|
Soleno Therapeutics Inc.  
|
|
1.78 -0.01 (-0.01%) |
01-17 09:30 |
|
Open: |
1.73 |
Pre close: |
1.79 |
Target:
|
2.39 
|
|
High: |
1.78 |
Low: |
1.78 |
Resistance:
|
2.05
2.39
|
|
Volume: |
9 |
Market Cap: |
56M |
Support:
|
1.68
1.45
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.80
 |
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
1.72 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
1.97 |
Stochastic Oscillator |
%K(14,3):
|
47.33 |
|
MA(250): |
2.03 |
%D(3): |
50.07 |
|
Average Volume(K) |
3-Month: |
7839
|
52-Week |
High:
|
3.60 |
|
10-Days: |
12981 |
Low: |
1.45 |
|
RSI |
RSI(14):
|
50.64 |
Change(%): |
-9.1 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-100.2 |
Shares Out. (M) |
21.44 |
|
EPS Est. Current Year |
-1.350 |
Return on Assets (ttm) |
-65.4 |
Shares Float (M) |
20.41 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.250 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
43.70 |
|
Forward EPS |
-0.791 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.750 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.65 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.68 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.35 |
P/CF |
-3.59 |
|
|
|
|
|
|
